Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Asthma (Formoterol (Easyhaler) - Asthma)

Records returned : 62 (on 04 Sep 2025 at 04:57:34). Return to search results for ' Asthma '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

LABA monotherapy no longer recommended for asthma or COPD.

Not to be initiated in new patients.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important
Preferred

Children only - ICS alone not recommended in adults with asthma.

First line ICS in children.

Prescribe by BRAND

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Not licensed in <18 years. ICS alone not recommended in adults with asthma.

Not to be initiated in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (breath actuated Metered Dose)
Restrictions / Comments:

Important

No dose counter, high carbon footprint.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (breath actuated Metered Dose)
Restrictions / Comments:

Important

No dose counter, high carbon footprint.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Children only - ICS alone not recommended in adults with asthma.

Second line ICS in children (Clenil Modulite is 1st line).

No dose counter.

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fostair NEXThaler 100/6 - licensed from 18 years of age.

Not licensed for AIR.

Second line in adult asthma requiring MART. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fostair NEXThaler 200/6 - High dose ICS/LABA for specialist* recommendation only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Not licensed for COPD.

Prescribe by BRAND.

 
Links :
Indication :
Status :
See narrative
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Not for initiation in new patients. Proxor device is the preferred beclometasone with formoterol pMDI.

Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.

Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Proxor 100/6 (new device) - licensed for MART in adults - second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Not licensed in under 18 years.

Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Proxor 200/6 (new device) - higher dose ICS/LABA for specialist* recommendation only.

Not licensed in under 18 years. Not licensed for COPD

Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Trimbow 87/5/9 and 172/5/9 - specialist* recommendation only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important
Preferred

Children only - ICS alone not recommended in adults with asthma.

DPI licensed in children, cost effective.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Children only - ICS alone not recommended in adults with asthma.

Licensed in children. Second line (Easyhaler budesonide device is preferred).

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist* recommendation following patient initiation and education on nebuliser therapy.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

DuoResp Spiromax 160/4.5 - licensed for AIR and MART from 12 years of age.

Second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

DuoResp Spiromax 320/9 - higher dose ICS/LABA for specialist* recommendation only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Prescribe by BRAND.

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important
Preferred

Fobumix Easyhaler 80/4.5 and 160/4.5 - licensed in children.

Cost-effective choice for AIR and MART.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fobumix Easyhaler 320/9 - higher dose ICS/LABA for specialist* recommendation only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Prescribe by BRAND.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Symbicort Turbohaler 100/6 and 200/6 - Licensed for AIR and MART.

More costly device so second line option. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Symbicort Turbohaler 400/12 - higher dose ICS/LABA for specialist* recommendation only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Flixotide Accuhaler - specialist* paediatric recommendation. 50 and 100mcg strength only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Children only - ICS alone not recommended in adults with asthma.

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Flixotide Evohaler - specialist* paediatric recommendation. 50 and 125 mcg strength only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Children only - ICS alone not recommended in adults with asthma.

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Flutiform 50/5 - For children aged 5 to 11 years needing ICS/LABA, unable to use DPI.

Not recommended for use in adults.

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Flutiform 125/5 and 250/10 - on request from specialist* team only.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Very high carbon footprint.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Not for initiation in new patients

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Seretide Evohaler 50/25 - for children aged 5 to 11 years needing ICS/LABA, unable to use DPI.

Not recommended for use in adults.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Relvar Ellipta 92/22 and 184/22 - higher dose ICS LABA for specialist* recommendation only.

Once daily formulation.

Prescribe by BRAND.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 

 
Links :
Indication :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist* recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Specialist* recommendation only.  Used in severe asthma.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Only triple therapy DPI licensed for asthma.

Prescribe by BRAND

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important
Preferred

Cost-effective, low carbon DPI.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist* recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (breath actuated Metered Dose)
Restrictions / Comments:

Important

Second line, as an alternative to Salbutamol Easyhaler, in patients needing a breath actuated inhaler

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

No dose counter. Lower carbon footprint than Ventolin Evohaler.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.

Prescribe by BRAND

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

No dose counter. Higher carbon footprint than the Salamol MDI.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Serevent Evohaler

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist* recommendation following patient initiation and education on nebuliser therapy.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Severe acute asthma
 
Links :
Indication :
Status :
Green
Formulations :
  • Soft mist inhaler
Restrictions / Comments:

Important

Only LAMA licensed in asthma.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device
Restrictions / Comments:

Important

AeroChamber Plus Flow-Vu Anti-Static - From 13 years

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device WITH MASK
Restrictions / Comments:

Important

From 13 years

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device WITH MASK
Restrictions / Comments:

Important

From 13 years

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device WITH MASK
Restrictions / Comments:

Important

From 1 to 5 years

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device WITH MASK
Restrictions / Comments:

Important

From 0 to 18 months

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device
Restrictions / Comments:

Important

From 5 to 12 years

 
Links :
Indication :
Status :
Green
Formulations :
  • Chewable tablets
  • Sachets (granules)
  • Tablets
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device
Restrictions / Comments:

Important

From 5 years.

Compatible with Clenil Modulite, Salamol and Seretide

 
Links :
Indication :
Status :
Green
Formulations :
  • Spacer device WITH MASK
Restrictions / Comments:

Important

4 years and under.

Compatible with Clenil Modulite, Salamol and Seretide

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Symbicort 100/3 - For use in children. Useful for patients needing a pMDI licensed for MART.

Prescribe by BRAND

 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialised commissioned services only.
 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Unlicensed use in under 12 years of age.
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Modified release tablets
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
See narrative
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.
 
Links :